204 related articles for article (PubMed ID: 27068437)
21. A subset of CD45+/CD19 - cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma.
Kim SM; Lee ST; Ryu KJ; Kim HJ; Kim SH; Ko YH; Kim WS; Kim SJ
Leuk Lymphoma; 2015; 56(11):3052-7. PubMed ID: 25739938
[TBL] [Abstract][Full Text] [Related]
22. Treatment strategies in mantle cell lymphoma.
Maddocks K; Blum KA
Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
[TBL] [Abstract][Full Text] [Related]
23. A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited.
Chen D; Ketterling RP; Hanson CA; Colgan JP; Zent CS; Viswanatha DS
Am J Surg Pathol; 2011 Jul; 35(7):1080-4. PubMed ID: 21677543
[TBL] [Abstract][Full Text] [Related]
24. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
25. Watch and Wait in Mantle Cell Lymphoma.
Lee C; Martin P
Hematol Oncol Clin North Am; 2020 Oct; 34(5):837-847. PubMed ID: 32861281
[TBL] [Abstract][Full Text] [Related]
26. New strategies in the treatment of mantle cell lymphoma.
Deng C; Lee S; O'Connor OA
Clin Cancer Res; 2012 Jul; 18(13):3499-508. PubMed ID: 22700864
[TBL] [Abstract][Full Text] [Related]
27. Mantle cell lymphoma-management in evolution.
Rajguru S; Kahl BS
Chin Clin Oncol; 2015 Mar; 4(1):8. PubMed ID: 25841715
[TBL] [Abstract][Full Text] [Related]
28. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
29. Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression.
Vogt N; Klapper W
Histopathology; 2013 Jan; 62(2):334-42. PubMed ID: 23240716
[TBL] [Abstract][Full Text] [Related]
30. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
31. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
Petković I; Stojnev S; Krstić M; Pejčić I; Vrbić S
Vojnosanit Pregl; 2016 Nov; 73(11):1072-5. PubMed ID: 29341562
[TBL] [Abstract][Full Text] [Related]
32. [Mantle cell lymphoma: Towards a personalized therapeutic strategy?].
Navarro Matilla B; García-Marco JA
Med Clin (Barc); 2015 Jun; 144(12):553-9. PubMed ID: 25023849
[TBL] [Abstract][Full Text] [Related]
33. Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma.
Prasad A; Shrivastava A; Papadopoulos E; Kuzontkoski PM; Reddy MV; Gillum AM; Kumar R; Reddy EP; Groopman JE
Clin Cancer Res; 2013 Jan; 19(1):85-95. PubMed ID: 23124440
[TBL] [Abstract][Full Text] [Related]
34. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.
Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y
Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830
[TBL] [Abstract][Full Text] [Related]
35. Should there be a standard therapy for mantle cell lymphoma?
Smith MR
Future Oncol; 2011 Feb; 7(2):227-37. PubMed ID: 21345142
[TBL] [Abstract][Full Text] [Related]
36. Key Clinical and Translational Research Questions to Address Unmet Needs in Mantle Cell Lymphoma.
Rodgers TD; Friedberg JW
Hematol Oncol Clin North Am; 2020 Oct; 34(5):983-996. PubMed ID: 32861291
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
[TBL] [Abstract][Full Text] [Related]
38. Management of mantle cell lymphoma: key challenges and next steps.
Williams ME; Dreyling M; Winter J; Muneer S; Leonard JP
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):336-46. PubMed ID: 21030346
[TBL] [Abstract][Full Text] [Related]
39. Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.
Sakai T; Masaki Y; Otsuki N; Sakamaki I; Kishi S; Miyazono T; Urasaki Y; Murakami J; Satoh T; Nakamura T; Iwao H; Nakajima A; Kawanami T; Miki M; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Ueda T
Med Oncol; 2015 Sep; 32(9):232. PubMed ID: 26275804
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic variations in mantle cell lymphoma.
Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]